13F
← All fund report cards

FARALLON CAPITAL MANAGEMENT LLC

13F equity value
$15.3B
Positions
169
Top 10 concentration
48.8%
Quarters / total new picks
32 / 263
13F equity value over time
$0M$11B$21B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +1.7% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 34.4% of quarters (excess t = -0.24, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
-0.9%
t-stat
-0.24
Quarterly win rate
34%
Annualized excess
-7.0%
$1 → follow vs universe
$1.23 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.02020180630: follow 0.86120180930: follow 0.93820181231: follow 0.86020190331: follow 1.02420190630: follow 0.95220190930: follow 1.53320191231: follow 1.41220200331: follow 1.34820200630: follow 1.42220200930: follow 1.51620201231: follow 1.33820210331: follow 1.31920210630: follow 1.46720210930: follow 1.33520211231: follow 1.20520220331: follow 1.50520220630: follow 1.28520220930: follow 1.30120221231: follow 1.16920230331: follow 1.07520230630: follow 1.01320230930: follow 1.20820231231: follow 1.11120240331: follow 1.07120240630: follow 0.99220240930: follow 1.03620241231: follow 0.91920250331: follow 0.90420250630: follow 1.14520250930: follow 1.27520251231: follow 1.231 0.79 1.52 2.25 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 169 · 2026 Q1

Ticker Value Weight QoQ
RVMD $1.3B
8.6%
TRIM
AMZN $879M
5.7%
TRIM
MSFT $868M
5.7%
ADD
AON $811M
5.3%
TRIM
BBIO $695M
4.5%
ADD
PTGX $669M
4.4%
ADD
NTRA $641M
4.2%
TRIM
EXEL $562M
3.7%
TRIM
AVGO $551M
3.6%
ADD
UNH $493M
3.2%
ADD
SNPS $481M
3.1%
ADD
BSX $469M
3.1%
HOLD
TMO $433M
2.8%
ADD
KKR $432M
2.8%
ADD
LNTH $424M
2.8%
ADD
WAB $402M
2.6%
TRIM
SCHW $372M
2.4%
ADD
LQDA $327M
2.1%
HOLD
CRNX $303M
2.0%
ADD
GOOG $286M
1.9%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.